The FBI has added Texas laboratory owner Emylee Thai to its Most Wanted Fraudster list after she allegedly orchestrated a $100 million healthcare fraud scheme involving medically unnecessary genetic testing. Authorities report Thai fled the United States via private aircraft using a fake identity in late 2022 and is believed to be hiding in Vietnam.
How the $100 Million Genetic Testing Scheme Operated
Federal investigators allege that Emylee Thai utilized her laboratory ownership to execute a large-scale kickback operation beginning in 2019. According to the FBI, Thai contracted with third-party marketers to secure signed doctors’ orders and DNA samples from beneficiaries. In exchange, the laboratory provided these marketers with a percentage of the insurance reimbursements.
The scheme relied on billing Medicare for genetic tests that were not medically necessary. FBI officials stated that many of these tests were never even used in the clinical treatment of the patients. Records show that Thai’s laboratory billed Medicare approximately $142 million for these services, resulting in roughly $95 million in payouts.
The FBI currently offers a reward of up to $150,000 for information leading directly to the arrest of Emylee Thai. Tips can be submitted by calling 1-800-CALL-FBI.
What Happened After the Initial Indictment?
Legal proceedings began in July 2022 when Thai was charged with conspiracy to commit healthcare fraud, conspiracy to defraud the United States, and paying kickbacks in federal programs. Following her arrest, a court granted Thai bail with specific conditions, including the requirement to wear a location monitoring device.
The situation shifted on Dec. 8, 2022, when authorities reported that Thai’s monitoring device was removed. Her last confirmed location was Harry Reid International Airport in Las Vegas. By the following day, officials had issued an arrest warrant. A year later, on July 5, 2023, the government filed additional charges against Thai for the destruction and alteration of records during the federal investigation.
Future Trends in Healthcare Fraud Enforcement
The case of Emylee Thai highlights a growing trend in federal oversight: the aggressive pursuit of “tele-fraud” and laboratory-based schemes. According to the Department of Justice, genetic testing fraud has become a primary focus for federal task forces, as these operations often exploit high Medicare reimbursement rates for diagnostic procedures.
Experts note that the rise of international flight by suspects—often facilitated by private aviation and forged documentation—presents a significant challenge for the FBI. This case sets a precedent for how federal agencies are increasingly utilizing the “Most Wanted” designation to apply public pressure on fugitives who have crossed international borders, particularly in jurisdictions where extradition may be complex.
Frequently Asked Questions
- What is Emylee Thai accused of?
She is accused of running a $100 million healthcare fraud scheme involving unnecessary genetic testing and illegal kickbacks. - Where is Emylee Thai currently located?
The FBI reports that she is likely in Vietnam after fleeing the U.S. on a private plane. - How can the public assist in this investigation?
The FBI asks that anyone with information regarding her whereabouts contact 1-800-CALL-FBI.
Healthcare providers and patients can protect themselves from similar schemes by verifying that genetic tests are ordered by a primary care physician who is actively involved in the patient’s treatment plan.
Stay informed on the latest federal investigations. Subscribe to our newsletter for updates on this case and other major developments in healthcare law.
Worth a look